People with type 2 diabetes (T2D) die from infections at a higher rate than similar people without diabetes, and the overall burden appears greater than previously reported. Deaths from infections as ...

Type 2 diabetes boosts the risk of infections like cellulitis. This higher risk may be due to several factors, such as the effects of diabetes on the immune system and the skin. Without treatment, ...

In adults with type 2 diabetes and nephrotic-range proteinuria, SGLT2 inhibitors are linked to lower risks for major adverse ...

Fractyl Health Inc. reported clinical updates on the Revita real world registry in Germany which has demonstrated clinical remission from type 2 diabetes (T2D) employing a device that resurfaces the ...

Compared with nonuse, GLP-1RA and thiazolidinedione combination therapy reduced risks for all-cause and cardiovascular mortality in type 2 diabetes. The combination of a glucagon-like peptide 1 ...

Fenofibrate as an adjunct to statins was associated with lower risks for all-cause mortality and cardiovascular disease among individuals with type 2 diabetes. Fenofibrate as an adjunct to statin ...